Intellectual Property India Publishes Patent Application for 'Ph-Dependent Anti-Cd3 Antibodies And Methods Relating Thereto' Filed by Adimab, Llc

MUMBAI, India, June 20 -- Intellectual Property India has published a patent application (202517024285 A) filed by Adimab, Llc, Lebanon, U.S.A., on March 18, for 'ph-dependent anti-cd3 antibodies and methods relating thereto.'

Inventor(s) include Battles, Michael, Benjamin; and Widboom, Paul.

The application for the patent was published on June 20, under issue no. 25/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides anti-CD3 antibodies and antigen-binding fragments and multispecific antibodies and antibody fragments thereof. The present disclosure further provides nucleic acids and vectors encoding such antibodies or antibody fragments and cells comprising such nucleic acids. Fu...